Amyris has cut a deal with Glycotech to provide a chemical processing facility to use Amyris’ renewable Farnesene for downstream applications.
CEO of Amyris, John Melo;
“We are excited to access this facility to perform our own chemical processing of farnesene into our target 2011 end products of squalane and lubricant. In addition, we can expand these operations to grow beyond our 2011 needs to support growth in several of our vertical markets.”
Farnesene is a chemical of high value in the flavors and fragrances sector, or as a building block for producing other chemicals, such as lubricants and cosmetics. Amyris’ process for renewable diesel production uses farnesene as a feedstock. There is also research and development underway to use farnesene in polymers. Amyris produces Farnesene under the name Biofene by microbial fermentation using renewable feedstocks and has number of business partners around the world to commercialise these various applications.
The latest in these partnerships is with Glycotech and Salisbury Partners for use of Salisbury’s processing facility in North Carolina. At first the facility will probably covert Amyris’ farnesene to squalene, with more conversions coming online in future. From here, Amyris will distribute the products itself. The financial benefits of the arrangement are that Amyris will be able to effectively outsource part of its production process, making the economics of the process better.
CEO of Amyris, John Melo;
“We are excited to access this facility to perform our own chemical processing of farnesene into our target 2011 end products of squalane and lubricant. In addition, we can expand these operations to grow beyond our 2011 needs to support growth in several of our vertical markets.”
Farnesene is a chemical of high value in the flavors and fragrances sector, or as a building block for producing other chemicals, such as lubricants and cosmetics. Amyris’ process for renewable diesel production uses farnesene as a feedstock. There is also research and development underway to use farnesene in polymers. Amyris produces Farnesene under the name Biofene by microbial fermentation using renewable feedstocks and has number of business partners around the world to commercialise these various applications.
The latest in these partnerships is with Glycotech and Salisbury Partners for use of Salisbury’s processing facility in North Carolina. At first the facility will probably covert Amyris’ farnesene to squalene, with more conversions coming online in future. From here, Amyris will distribute the products itself. The financial benefits of the arrangement are that Amyris will be able to effectively outsource part of its production process, making the economics of the process better.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.